ICIG completes acquisition of Sandoz site

By Melissa Fassbender contact

- Last updated on GMT

Sandoz will be re-named Corden BioChem GmbH. (Image: iStock)
Sandoz will be re-named Corden BioChem GmbH. (Image: iStock)

Related tags: Metabolism

International Chemical Investors Group (ICIG) has completed its acquisition of Sandoz Industrial Products GmbH from Novartis Group.

The previously announced agreement between ICIG’s pharma platform, CordenPharma, and the Frankfurt-Höchst-based manufacturer of enzyme-based fermentation products and intermediates was established in February of this year.

The new site will expand the CordenPharma’s operations, specifically growing its enzymes-based manufacturing portfolio and antibiotics technology platform, adding new capabilities in microbial fermentation and enzymatic reactions.

As Outsourcing-Pharma.com reported​, the acquisition will establish CordenPharma as one of the major suppliers of 7-ACA to customers worldwide. Additionally, the company will use the material in-house for its anitbiotics value chain located in Latina, Itay.

Sandoz will maintain its operations associated with the CordenPharma Group, ICIG’s pharma platform, and will be re-named Corden BioChem GmbH.

Corden BioChem will be complementary to both ICIG’s pharma activities as well as to its fine chemicals activities within the WeylChem Group,​” the company commented in its announcement. “The site represents an important additional building block of fermentation-based production technology for ICIG​.”

Achim Riemann, ICIG Owner, told us that CordenBiochem has become part of the company's antibiotics platform within CordenPharma and "will be managed as a profit center like all other companies of the group using the services and Support functions of the group​." He added, "CordenPharma has the ambition to grow further and plans add on acquisitions in API and drug product manufacturing​."

Related news

Show more

Related products

show more

Flexible Filling Solution for CMOs

Flexible Filling Solution for CMOs

Single Use Support GmBH | 18-May-2022 | Insight Guide

Achieving flexibility requires modularity of technologies.

CMOs and CDMOs aspire to be flexible for multiple applications. Efficient automated...

Eastern & Western Manufacturing Solutions

Eastern & Western Manufacturing Solutions

Piramal Pharma Solutions | 15-Mar-2022 | Technical / White Paper

The best manufacturing site for a product can change throughout the life cycle. When bringing new drugs to market, biopharma companies may benefit from...

Related suppliers

Follow us


View more